Glaukos Corporation

GKOS ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $90.8M $169.6M $93.5M $119.5M $100.7M $96.6M $62.4M $29.8M
Accounts Receivable $108.6M $60.7M $39.9M $36.1M $33.4M $36.1M $38.4M $18.7M
Inventory $63.6M $57.7M $42.0M $37.8M $23.0M $15.8M $42.6M $13.3M
Total Current Assets $475.0M $449.8M $395.5M $443.9M $486.1M $469.4M $262.9M $176.6M
Property, Plant & Equipment $113.3M $97.9M $103.2M $94.4M $69.0M $24.0M $22.1M $19.2M
Goodwill $66.7M $66.1M $66.1M $66.1M $66.1M $66.1M $66.1M —
Intangible Assets (Excl. Goodwill) $141.9M $263.4M $283.0M $307.9M $332.8M $357.7M $382.6M —
Total Assets $893.5M $974.8M $940.4M $1.00B $1.05B $1.01B $818.4M $207.0M
Liabilities
Accounts Payable $24.6M $13.0M $13.4M $14.4M $7.3M $4.4M $5.8M $6.3M
Total Current Liabilities $101.3M $75.1M $74.0M $72.4M $63.4M $49.7M $57.7M $30.4M
Long-Term Debt — — — — — — — —
Total Liabilities $237.3M $207.8M $478.6M $472.4M $462.5M $338.1M $145.1M $33.1M
Stockholders' Equity
Retained Earnings $-933.1M $-745.4M $-599.1M $-464.4M $-365.2M $-310.1M $-189.7M $-205.1M
Total Stockholders' Equity $656.2M $766.9M $461.8M $530.0M $587.2M $667.4M $673.3M $173.9M
← Newer Page 1 of 2 Older →